Multiple Myeloma in Adolescent and Young Adults: An ASCO CancerLinQ and SEER Analysis

RWD from ASCO's CancerLinQ Discovery MM dataset (n  = 1946) and SEER (n = 1334) were used to characterize AYA MM patients. AYAs were more likely to develop ALL, AML, and infections and less likely to develop nonmelanoma skin cancer, prostate cancer, and VTE. Despite a longer OS, most AYAs died of MM (68.3%), other primary malignancy (7.5%, mostl y leukemia), and cardiovascular events (5.2%).

Source: Clinical Lymphoma, Myeloma and Leukemia - July 28, 2023 Category: Hematology Authors: Steven Gibson, Jennifer Thornton, Kevin Sunderland, Kevin Pham, Christin DeStefano Source Type: research